The Vanishing Adrenal Glands: A Transient Regression of Adrenal Lymphoma After a Single Dose of 1 mg Dexamethasone.

ACTH, adrenocorticotropic hormone CT, computed tomography DLBCL, diffuse large B-cell lymphoma ONDST, overnight dexamethasone suppression test PAI, primary adrenal insufficiency PET, positron emission tomography SST, short synacthen test adrenal adrenal cancer adrenal insufficiency

Journal

AACE clinical case reports
ISSN: 2376-0605
Titre abrégé: AACE Clin Case Rep
Pays: United States
ID NLM: 101670593

Informations de publication

Date de publication:
Historique:
entrez: 7 6 2021
pubmed: 8 6 2021
medline: 8 6 2021
Statut: epublish

Résumé

Dexamethasone is a known treatment for lymphoma, but the potency and rapidity of its effect have not been recognized. We present a case of bilateral adrenal lymphoma that significantly reduced in size after a single dose of dexamethasone. We present the clinical course and investigations, including adrenocorticotropic hormone, cortisol, short synacthen test, computed tomography (CT), and adrenal biopsy results. A 52-year-old man had a fall and was incidentally found to have bilateral adrenal masses (left, 6 cm; right, 5 cm) on CT. His adrenal function tests included plasma metanephrines (normetanephrine, 830 pmol/L [normal, <1180]; metanephrine, <100 pmol/L [<510]; 3-methoxytyramine, <100 pmol/L [<180]); aldosterone, 270 pmol/L( 90-700); and random cortisol, 230 nmol/L (160-550). An overnight dexamethasone suppression test with 1 mg of dexamethasone showed cortisol of <28 nmol/L (0-50). A repeat CT scan 8 days thereafter showed adrenal masses of 4.5 and 3.5 cm on the left and right, respectively. He had a follow-up CT scan 3 months later that showed adrenal lesions measuring 8 cm (left) and 9 cm (right). He subsequently presented with fatigue and dizziness. Morning cortisol of 201 nmol/L (160-550) with adrenocorticotropic hormone of 216 ng/L (10-30) indicated primary adrenal insufficiency. Mineralocorticoid and glucocorticoid replacement therapy commenced. An adrenal biopsy showed abnormal enlarged B cells, consistent with a diagnosis of diffuse large B-cell lymphoma. A diagnosis of lymphoma should be considered when adrenal lesions shrink following even a single low dose of dexamethasone administered as a part of a diagnostic test.

Identifiants

pubmed: 34095465
doi: 10.1016/j.aace.2020.11.022
pii: S2376-0605(20)31023-3
pmc: PMC8053686
doi:

Types de publication

Case Reports

Langues

eng

Pagination

109-112

Informations de copyright

© 2020 AACE. Published by Elsevier Inc.

Références

Ann Hematol. 2013 Dec;92(12):1583-93
pubmed: 23771429
J Med Imaging Radiat Oncol. 2012 Dec;56(6):636-45
pubmed: 23210583
Turk Neurosurg. 2007 Apr;17(2):129-33
pubmed: 17935030
J Hematol Oncol. 2012 Aug 13;5:49
pubmed: 22889180
Trials. 2012 Aug 21;13:141
pubmed: 22909281
ORL J Otorhinolaryngol Relat Spec. 2014;76(4):189-92
pubmed: 25138135
Korean J Hematol. 2012 Dec;47(4):293-7
pubmed: 23320009
Intern Med. 2017 Sep 1;56(17):2261-2269
pubmed: 28794358
Endocrinol Diabetes Metab Case Rep. 2020 Mar 10;2020:
pubmed: 32163909
Chest. 1995 Jun;107(6):1486-7
pubmed: 7781334

Auteurs

Shamaila Zaman (S)

Imperial Centre for Endocrinology and Diabetes, Imperial College Healthcare NHS Trust, London, United Kingdom.

Hessa Boharoon (H)

Imperial Centre for Endocrinology and Diabetes, Imperial College Healthcare NHS Trust, London, United Kingdom.

Neelam Khalid (N)

Imperial Centre for Endocrinology and Diabetes, Imperial College Healthcare NHS Trust, London, United Kingdom.

Sasha Marks (S)

Haematology Department, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.

Ali Alsafi (A)

Imaging Department, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.

Rashpal Flora (R)

Pathology Department, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.

Neil Hill (N)

Imperial Centre for Endocrinology and Diabetes, Imperial College Healthcare NHS Trust, London, United Kingdom.

Emma Hatfield (E)

Imperial Centre for Endocrinology and Diabetes, Imperial College Healthcare NHS Trust, London, United Kingdom.

Karim Meeran (K)

Imperial Centre for Endocrinology and Diabetes, Imperial College Healthcare NHS Trust, London, United Kingdom.

Classifications MeSH